Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, ProQR Therapeutics N.V (NASDAQ: PRQR) closed at $2.04 up 0.99% from its previous closing price of $2.02. In other words, the price has increased by $0.99 from its previous closing price. On the day, 1.35 million shares were traded.
Ratios:
For a deeper understanding of ProQR Therapeutics N.V’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.33. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.46.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $15.
On October 29, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $6 to $14.
Chardan Capital Markets Upgraded its Neutral to Buy on November 08, 2023, while the target price for the stock was maintained at $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.87 while its Price-to-Book (P/B) ratio in mrq is 5.98.
Stock Price History:
Over the past 52 weeks, PRQR has reached a high of $4.62, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -14.33%, while the 200-Day Moving Average is calculated to be -14.24%.
Shares Statistics:
A total of 81.68M shares are outstanding, with a floating share count of 69.41M. Insiders hold about 32.74% of the company’s shares, while institutions hold 43.14% stake in the company.
